Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44358 clinical trials with a EudraCT protocol, of which 7384 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,358)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,358 result(s) found. Displaying page 267 of 2,218.

EudraCT Number: 2016-004949-92	Sponsor Protocol Number: E2020-A001-336	Start Date*: 2017-03-09
Sponsor Name:Eisai Inc.
Full Title: A 10-Week, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in the Treatment of the Cognitive Dysfunction Exhibited by Children with...
Medical condition: Down Syndrome, Cognitive Dysfunction
Disease:
Population Age: Children, Under 18		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: View results

EudraCT Number: 2017-004405-41

Sponsor Protocol Number: CLI-05993BA1-02

Start Date*: 2018-09-06

Sponsor Name:Chiesi Farmaceutici S.p.A.

Full Title: A phase II, multicentre, randomised, double-blind, double-dummy, active-controlled, 3-way cross-over study to evaluate the efficacy of CHF 5993 administered via Dry Powder Inhaler (DPI) versus CHF ...

Medical condition: chronic obstructive pulmonary disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004855	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) CZ (Completed) BG (Completed) PL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2015-004031-12

Sponsor Protocol Number: AC15007

Start Date*: 2017-01-05

Sponsor Name:University of Edinburgh [...]

Full Title: Serelaxin To Lower Portal Pressure in Patients with Cirrhosis and Portal Hypertension (STOPP)

Medical condition: Portal hypertension in patients with liver cirrhosis.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	10019805 - Hepatobiliary disorders	10036200	Portal hypertension	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2014-003305-15	Sponsor Protocol Number: UW12-141	Start Date*: 2015-01-21
Sponsor Name:HK Clinical Trials
Full Title: Prospectuve study on the treatment of normal tension glacuoma with selective laser trabeculoplasty
Medical condition: Normal tension glaucoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: (No results available)

EudraCT Number: 2017-002686-21

Sponsor Protocol Number: WVE-DMDX51-001

Start Date*: 2018-04-11

Sponsor Name:Wave Life Sciences Ltd.

Full Title: A Multicenter, Double-blind, Placebo-controlled, Phase 1 Study of WVE-210201 Administered Intravenously to Patients with Duchenne Muscular Dystrophy

Medical condition: Duchenne Muscular Dystrophy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10010331 - Congenital, familial and genetic disorders	10013801	Duchenne muscular dystrophy	PT

Population Age: Children, Adolescents, Under 18

Gender: Male

Trial protocol: GB (Completed) FR (Completed) BE (Completed) NL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2014-004334-26

Sponsor Protocol Number: N01222

Start Date*: 2015-02-10

Sponsor Name:UCB Japan Co. Ltd

Full Title: A Multicenter, Open, Long-term Follow-up Study to Evaluate the Safety and Efficacy of L059 (Levetiracetam) at Individual Optimal Dose Ranging From 500 to 3000 mg/Day in Twice Daily Administration i...

Medical condition: Epilepsies Partial

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	10029205 - Nervous system disorders	10015037	Epilepsy	PT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2017-003460-13

Sponsor Protocol Number: GN16CA007

Start Date*: 2018-02-13

Sponsor Name:NHS Greater Glasgow and Clyde [...]

Full Title: The effects of sacubitril/valsartan compared to valsartan on left ventricular remodelling in patients with asymptomatic left ventricular systolic dysfunction after myocardial infarction: a randomi...

Medical condition: Asymptomatic (New York Heart Association ≤2) left ventricular systolic dysfunction (defined as ejection fraction ≤40% measured by Simpson's biplane using transthoracic echocardiography) at least 3...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10019279	Heart failure	LLT
	20.1	10007541 - Cardiac disorders	10064079	Heart failure NYHA class I	LLT
	20.0	10007541 - Cardiac disorders	10069501	Left ventricular systolic dysfunction	LLT
	20.0	10007541 - Cardiac disorders	10000891	Acute myocardial infarction	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2014-003138-18

Sponsor Protocol Number: UCC-Strider

Start Date*: Information not available in EudraCT

Sponsor Name:University College Cork

Full Title: STRIDER Ireland: A Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early‐Onset Intrauterine Growth Restriction

Medical condition: Severe early - onset Intrauterine Growth Restriction (IUGR), (also referred to as Fetal growth restriction) diagnosed between 22+0 and 29+6 gestational age. IUGR is defined as an estimated fetal we...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004868	10070532	Fetal growth restriction	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Female

Trial protocol: IE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2014-002134-31	Sponsor Protocol Number: HLS14/01	Start Date*: 2015-07-22
Sponsor Name:Ospedale L. Sacco - Azienda Ospedaliera-Polo Universitario
Full Title: Evalutation of maraviroc therapy in PI-treated HIV+ patients at intermediate-low risk for cardiovascular diseases: a phase IV, randomized, open study
Medical condition: HIV-1 infection.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2014-005105-20	Sponsor Protocol Number: V48P4E3	Start Date*: 2014-11-28
Sponsor Name:Novartis Vaccines and Diagnostics
Full Title: A phase IV, uncontrolled, open-label, multi-center study in children and adolescents: Evaluation of long-term immunogenicity in subjects boosted with a new pediatric TBE vaccine (free of protein-de...
Medical condition: Prophylaxis: Tick-borne-encephalitis
Disease:
Population Age: Children, Under 18		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: View results

EudraCT Number: 2014-005028-92

Sponsor Protocol Number: BC3-CT011

Start Date*: 2015-01-06

Sponsor Name:Adocia

Full Title: Blood glucose control with BC222 insulin lispro compared to insulin lispro (Humalog®) after ingestion of a standardised meal.

Medical condition: Diabetes mellitus type 1

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	10027433 - Metabolism and nutrition disorders	10067584	Type 1 diabetes mellitus	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2014-005083-15	Sponsor Protocol Number: V72_42	Start Date*: 2014-12-03
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l.
Full Title: A Phase 3, Randomized, Observer-blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Novartis rMenB+OMV NZ Vaccine in Healthy Subjects Aged 11 to 17 years in Korea.
Medical condition: Prophylaxis Aganist Invasive Group B Meningococcal Disease
Disease:
Population Age: Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: View results

EudraCT Number: 2014-001014-25

Sponsor Protocol Number: FBB-DBS-2014

Start Date*: 2016-07-20

Sponsor Name:Fundació Clínic per la Recerca Biomèdica

Full Title: Brain Amyloid-Beta burden as per florbetaben (Neuraceq) pet and cognitive outcomes after deep brain stimulation in Parkinsin's disease

Medical condition: Parkinson's Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029205 - Nervous system disorders	10061536	Parkinson's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2015-003227-66

Sponsor Protocol Number: BP29937

Start Date*: 2016-09-27

Sponsor Name:F. Hoffmann-La Roche Ltd

Full Title: A randomized, double-blind, placebo-controlled, parallel group, safety, efficacy and pharmacodynamic study of basmisanil (RO5186582) in adults with severe motor impairment following an ischemic stroke

Medical condition: Stroke Motor Recovery

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029205 - Nervous system disorders	10061256	Ischaemic stroke	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Prematurely Ended)

Trial results: View results

EudraCT Number: 2015-003562-90

Sponsor Protocol Number: VHCRP1405

Start Date*: 2016-06-17

Sponsor Name:The Kirby Institute - UNSW Australia

Full Title: A phase IV open-label, multicentre, international trial of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin for people with chronic hepatitis C virus genotype 1 infection and...

Medical condition: Chronic hepatitis C virus genotype 1 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	100000004848	10072844	Hepatitis C virus genotype 1a positive	LLT
	19.0	100000004848	10072845	Hepatitis C virus genotype 1b positive	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2016-005165-31

Sponsor Protocol Number: LPS14914

Start Date*: 2020-05-14

Sponsor Name:Sanofi Aventis Groupe

Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Comparative Study to Assess the Efficacy and Safety of Spores of Enterogermina in Combination with Oral Rehydration Ther...

Medical condition: Acute diarrhea

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10017947 - Gastrointestinal disorders	10012735	Diarrhoea	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2016-000165-23

Sponsor Protocol Number: INFORM

Start Date*: 2016-10-19

Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

Full Title: ComparIsoN oF Optimal Hypertension RegiMens (Part of the Ancestry Informative Markers in Hypertension (AIM HY) Programme – AIM HY-INFORM)

Medical condition: Cardiovascular Hemodynamics

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004848	10005727	Blood pressure	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2017-000342-22

Sponsor Protocol Number: VALACT-2017-01

Start Date*: 2017-04-04

Sponsor Name:Dr. Luis Fernández-Dr. Jesus Barrio

Full Title: A randomized, double-blind, placebo-controlled study of the usefulness of the probiotic 'Lactobacillus reuteri' in the therapy of quadruple eradication of Helicobacter pylori infection in usual cli...

Medical condition: Helicobacter Pylori infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	100000004862	10019377	Helicobacter pylori infection	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2013-004532-30

Sponsor Protocol Number: MRZ60201_3091_1

Start Date*: 2014-12-09

Sponsor Name:Merz Pharmaceuticals GmbH

Full Title: Prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of...

Medical condition: Chronic troublesome sialorrhea associated with neurological disorders (e.g. cerebral palsy, traumatic brain injury) and/or intellectual disability in children and adolescents

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10017947 - Gastrointestinal disorders	10039424	Salivary hypersecretion	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: HU (Completed) PL (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2014-001972-70

Sponsor Protocol Number: PII116678

Start Date*: 2015-05-04

Sponsor Name:GlaxoSmithKline Reasearch & Development

Full Title: A randomised, double-blind (sponsor unblinded), placebocontrolled, parallel-group, multicentre study to evaluate the efficacy and safety of GSK2269557 administered in addition to standard of care i...

Medical condition: Chronic Obstructive Pulmonary Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004855	10010953	COPD exacerbation	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) NL (Completed) DK (Completed) RO (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Sep 02 21:18:57 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA